Metformin-induced reduction of CCR8 enhances the anti-tumor immune response of PD-1 immunotherapy in glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metformin-induced reduction of CCR8 enhances the anti-tumor immune response of PD-1 immunotherapy in glioblastoma

Published:2024-02 Issue: Volume:964 Page:176274
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Li Yanyan,Liu Bin,Cao Yufei,Cai Lize,Zhou Youxin,Yang Wei,Sun Ting^ORCID

Publisher

Elsevier BV

Subject

Pharmacology

Reference36 articles.

1. Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target;Abdelfattah;Nat. Commun.,2022

2. Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma;Afzal;J Immunother Cancer,2018

3. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs;Allan;J. Clin. Invest.,2005

4. Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study;Augustin;Front. Oncol.,2023

5. Challenges in glioblastoma research: focus on the tumor microenvironment;Bikfalvi;Trends Cancer,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP